Issue Date: March 12, 2012
Small and Start-up pharmaceutical companies must juggle a lot of balls as they move potential drugs toward the market. They are conducting animal and human trials of their compounds. They are meting out cash carefully while courting investors for more funds. And they are looking ahead to potential big pharma partners in the fortunate event that the trials are successful and their drugs show commercial potential.
The last thing these companies want to worry about . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society